Tender detail
Open-house discount contracts for medicines containing Ebastine (ATC R06AX22)
Summary
The tender concerns open-house non-exclusive discount contracts for medicines containing the active substance Ebastine (ATC R06AX22) valid from 01 November 2026 to 31 October 2028, with the possibility to conclude contracts at any time. In the Open House procedure, medicines listed as pediatric medicines on the BfArM list are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.